Halpin T J, Holtzhauer F J, Campbell R J, Hall L J, Correa-Villaseñor A, Lanese R, Rice J, Hurwitz E S
JAMA. 1982 Aug 13;248(6):687-91.
Ninety-seven Reye's syndrome (RS) cases in Ohio children with onsets from December 1978 through March 1980 were studied for medication use during their pre-RS illness. They were matched with 156 control subjects for age, race, sex, geographic location, time, and type of illness. Only the use of aspirin was reported by significantly more cases (97%, 94/97) than controls (71%, 110/156) during the pre-RS matched illness. Using a multiple logistic model to control for the presence of fever, headache, and sore throat statistically, the difference in aspirin use remained significant. Conversely, fewer cases (16%) took medications containing acetaminophen than controls (33%). In 87% of the cases receiving aspirin, their maximum daily dosage did not exceed recommended levels, but their doses were higher than those of controls receiving aspirin. No relationship was found between dosage and stage of RS encephalopathy.
对1978年12月至1980年3月发病的俄亥俄州儿童中的97例瑞氏综合征(RS)病例在其RS发病前疾病期间的用药情况进行了研究。将他们与156名对照者在年龄、种族、性别、地理位置、时间和疾病类型方面进行匹配。在RS发病前匹配的疾病期间,报告使用阿司匹林的病例(97%,94/97)显著多于对照者(71%,110/156)。使用多元逻辑模型对发热、头痛和喉咙痛的存在进行统计学控制后,阿司匹林使用的差异仍然显著。相反,服用含对乙酰氨基酚药物的病例(16%)少于对照者(33%)。在87%服用阿司匹林的病例中,其最大日剂量未超过推荐水平,但他们的剂量高于服用阿司匹林的对照者。未发现剂量与RS脑病阶段之间存在关联。